MXPA06001173A - Metodo analitico para la pancreatina y composiciones comparables. - Google Patents

Metodo analitico para la pancreatina y composiciones comparables.

Info

Publication number
MXPA06001173A
MXPA06001173A MXPA06001173A MXPA06001173A MXPA06001173A MX PA06001173 A MXPA06001173 A MX PA06001173A MX PA06001173 A MXPA06001173 A MX PA06001173A MX PA06001173 A MXPA06001173 A MX PA06001173A MX PA06001173 A MXPA06001173 A MX PA06001173A
Authority
MX
Mexico
Prior art keywords
pancreatin
analytical method
mixtures
comparable compositions
enzyme mixtures
Prior art date
Application number
MXPA06001173A
Other languages
English (en)
Inventor
Bernd Thumbeck
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of MXPA06001173A publication Critical patent/MXPA06001173A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/994—Pancreatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La presente invencion se refiere a un metodo nuevo para analizar la identidad, secuencia de proteina y/o secuencia peptidica asi como la estabilidad de muestras que contienen mezclas de enzimas aceptables fisiologicamente con actividad lipolitica, proteolitica y amilolitica, pero especialmente de mezclas de enzimas digestivas tales como la pancreatina, en particular en el contexto de la fabricacion de productos medicinales que comprende dichas mezclas de enzimas, por ejemplo la pancreatina precipitada o mini microesferas de pancreatina.
MXPA06001173A 2003-07-29 2004-07-26 Metodo analitico para la pancreatina y composiciones comparables. MXPA06001173A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49051003P 2003-07-29 2003-07-29
PCT/EP2004/008332 WO2005012911A1 (en) 2003-07-29 2004-07-26 Analytical method for pancreatin and comparable compositions

Publications (1)

Publication Number Publication Date
MXPA06001173A true MXPA06001173A (es) 2006-04-11

Family

ID=34115404

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06001173A MXPA06001173A (es) 2003-07-29 2004-07-26 Metodo analitico para la pancreatina y composiciones comparables.

Country Status (11)

Country Link
US (1) US7479378B2 (es)
EP (1) EP1651962B1 (es)
JP (1) JP4891766B2 (es)
CN (1) CN1809753B (es)
AU (1) AU2004260961B2 (es)
BR (1) BRPI0413076B8 (es)
CA (1) CA2528906C (es)
HK (1) HK1091897A1 (es)
MX (1) MXPA06001173A (es)
RU (1) RU2359270C2 (es)
WO (1) WO2005012911A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8100844B2 (en) * 2002-04-25 2012-01-24 Ultraflex Systems, Inc. Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
DE602005009677D1 (de) * 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
WO2007014896A1 (en) 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2007139989A2 (en) * 2006-05-26 2007-12-06 Brandeis University Tissue sample preparation, and maldi ms imaging thereof
CA2704284A1 (en) * 2007-08-30 2009-03-12 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) * 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
NZ593823A (en) 2009-01-06 2013-09-27 Curelon Llc Compositions and methods for the treatment or the prevention of infections by e. coli
ES2668909T3 (es) 2009-01-06 2018-05-23 Galenagen, Llc Composiciones que comprenden proteasa, amilasa y lipasa para su uso en el tratamiento de infecciones por Staphylococcus aureus
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
JP5190422B2 (ja) * 2009-08-04 2013-04-24 ホーユー株式会社 等電点電気泳動用膨潤ゲルの作成方法
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
MX347770B (es) 2011-04-21 2017-05-12 Curemark Llc Compuesto para el tratamiento de alteraciones neuropsiquiatricas.
US9291630B1 (en) * 2011-08-29 2016-03-22 Scientific Protein Laboratories, Llc RP-HPLC method for the analysis and quantification of pancreatin active pharmaceutical agents
US9063034B1 (en) * 2011-10-17 2015-06-23 Scientific Protein Laboratories, Llc Determination of the absence or presence of Bacillus cereus enterotoxin via a western blot
US10151726B2 (en) 2011-11-14 2018-12-11 King Saud University Bioimaging nucleic acids, proteins and enzymes
US9677114B1 (en) * 2012-04-18 2017-06-13 Scientific Protein Laboratories, Llc Method for evaluating degradation pathways for pancreatin active pharmaceutical agents
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
CN103278453A (zh) * 2013-03-09 2013-09-04 青海省农林科学院 利用双向电泳和maldi-tof-ms技术获得小麦根相关抗旱蛋白的方法
CN105891303A (zh) * 2016-05-10 2016-08-24 江苏省农业科学院 利用双向电泳技术检测产琥珀酸放线杆菌中酶的方法
CN111220720B (zh) * 2019-12-05 2022-07-22 上海上药第一生化药业有限公司 胰蛋白酶及其酶原的纯度检测方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
WO2022201057A1 (en) * 2021-03-23 2022-09-29 Kashiv Biosciences, Llc Method for size based evaluation of pancreatic protein mixture

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2512746C3 (de) * 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
DE3377506D1 (en) * 1982-12-30 1988-09-01 Nordmark Arzneimittel Gmbh Process for obtaining pancreatin
GB9624927D0 (en) * 1996-11-29 1997-01-15 Oxford Glycosciences Uk Ltd Gels and their use
HUP0004338A2 (hu) * 1997-11-28 2001-02-28 Innogenetics N.V. Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai
US20020098595A1 (en) * 2000-02-08 2002-07-25 The Regents Of The University Of Michigan Protein separation and display
US6537434B1 (en) * 2000-07-21 2003-03-25 Large Scale Proteomics Corporation First dimension electrophoresis separation method and apparatus
JP4141834B2 (ja) * 2000-10-23 2008-08-27 ジェネティックス インスティテュート エルエルシー マトリックス支援レーザー脱離イオン化マススペクトロメトリーを使用したハイスループットなタンパク質の同定及び定量のための同位体コードイオン化増強試薬（ｉｃｉｅｒ）
JP2003042956A (ja) * 2001-07-31 2003-02-13 Fuji Photo Film Co Ltd データの読み取り方法およびそれに用いるスキャナ
JP2003083893A (ja) * 2001-09-17 2003-03-19 Tadashi Matsunaga サブマイクロ粒子表面における蛍光測定法
JP2003194775A (ja) * 2001-12-28 2003-07-09 Japan Science & Technology Corp タンパク質の電気泳動法

Also Published As

Publication number Publication date
AU2004260961B2 (en) 2010-05-20
EP1651962A1 (en) 2006-05-03
CA2528906C (en) 2013-07-16
BRPI0413076A (pt) 2006-10-03
AU2004260961A1 (en) 2005-02-10
CA2528906A1 (en) 2005-02-10
EP1651962B1 (en) 2013-09-11
HK1091897A1 (en) 2007-01-26
US20050112743A1 (en) 2005-05-26
US7479378B2 (en) 2009-01-20
RU2359270C2 (ru) 2009-06-20
RU2006105780A (ru) 2007-09-10
CN1809753B (zh) 2010-10-20
BRPI0413076B8 (pt) 2021-07-27
JP4891766B2 (ja) 2012-03-07
WO2005012911A1 (en) 2005-02-10
CN1809753A (zh) 2006-07-26
JP2007500343A (ja) 2007-01-11
BRPI0413076B1 (pt) 2016-06-28

Similar Documents

Publication Publication Date Title
MXPA06001173A (es) Metodo analitico para la pancreatina y composiciones comparables.
Sabbione et al. Amaranth peptides with antithrombotic activity released by simulated gastrointestinal digestion
Vishwanatha et al. Characterisation of acid protease expressed from Aspergillus oryzae MTCC 5341
Araujo et al. Peptidase specificity characterization of C-and N-terminal catalytic sites of angiotensin I-converting enzyme
PT1162995E (pt) Enzimas para o tratamento da diabetes mellitus do tipo i
Magalhães et al. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus
UA89944C2 (ru) Продуцирование высокоманнозных белков в растительных культурах
WO2001083782A3 (en) Novel proteases
Valente et al. Bothrops insularis venomics: a proteomic analysis supported by transcriptomic-generated sequence data
NZ596269A (en) Protease screening methods and proteases identified thereby
MXPA03002218A (es) Peptidos antimicrobianos y metodos de uso.
AU3368497A (en) Human dnase i hyperactive variants
Georgieva et al. Pseudechis australis venomics: adaptation for a defense against microbial pathogens and recruitment of body transferrin
EA200601823A1 (ru) Новые липазы и их применение
Odani et al. The inhibitory properties and primary structure of a novel serine proteinase inhibitor from the fruiting body of the basidiomycete, Lentinus edodes
Okamoto et al. PI class metalloproteinase from Bothrops moojeni venom is a post-proline cleaving peptidase with kininogenase activity: Insights into substrate selectivity and kinetic behavior
AU2003243097A1 (en) Novel compounds
Sharma et al. Benghalensin, a highly stable serine protease from the latex of medicinal plant Ficus benghalensis
Capiralla et al. Purification and characterization of a hydrophobic amino acid—specific endopeptidase from Halobacterium halobium S9 with potential application in debittering of protein hydrolysates
Dziuba et al. Bioinformatic-aided prediction for release possibilities of bioactive peptides from plant proteins
Dolečková et al. The functional expression and characterisation of a cysteine peptidase from the invasive stage of the neuropathogenic schistosome Trichobilharzia regenti
Jurgilas et al. PO41, a snake venom metalloproteinase inhibitor isolated from Philander opossum serum
HK1052026A1 (en) Human enzymes of the metalloprotease family
AU2001289034A1 (en) Novel pdes and uses thereof
DE60044038D1 (de) Xylosyltransferase und isoformen

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status
GB Transfer or rights